Literature DB >> 32356236

Two nomograms based on CT features to predict tumor invasiveness of pulmonary adenocarcinoma and growth in pure GGN: a retrospective analysis.

Taichun Qiu1,2, Xiaoshuang Ru3, Ke Yin2, Jing Yu2, Yang Song3, Jianlin Wu4.   

Abstract

PURPOSE: The aim of the study is to construct two nomograms for predicting the invasive extent of pulmonary adenocarcinoma and nodule growth in patients with pulmonary pure ground-glass nodules (pGGN).
METHOD: Consecutive patients with pGGNs (n = 172) were retrospectively studied at one institution, formed the development cohort in predicting IPAs' nomogram. A separate cohort of patients with pGGNs (n = 116) from another institution was used for validation. For the predicting growth nomogram, the primary cohort of patients with pGGNs (n = 80) was from the former institution. We developed the nomogram for predicting IPA using binary logistic regression model, and a Cox multivariable model for the growth nomogram. We assessed nomogram model performance by calibration and discrimination (C-index).
RESULTS: The variables selected in binary logistic regression model (lesion size and shape) had a significant effect on identifying IPA from preinvasive lesion. The C-index of the development and validation cohort were 0.819 (95% CI 0.753-0.874) and 0.811 (95% CI 0.728-0.878), respectively. The risk variables (lesion size, blood vessel types) were selected in the multivariable Cox model. The C-index was 0.880 in the development cohort.
CONCLUSION: Our nomograms are reliable prognostic methods that can predict the invasiveness of pulmonary adenocarcinomas and the growth of pure GGN in preoperative.

Entities:  

Keywords:  Follow-up study; Lung adenocarcinoma; Models; Solitary pulmonary nodule; Spiral computed tomography; Statistical

Mesh:

Year:  2020        PMID: 32356236     DOI: 10.1007/s11604-020-00957-x

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  1 in total

1.  Long-term prognosis of video-assisted limited surgery for early lung cancer.

Authors:  Kazuro Sugi; Seiki Kobayashi; Manabu Sudou; Hisashi Sakano; Eisuke Matsuda; Kazunori Okabe
Journal:  Eur J Cardiothorac Surg       Date:  2009-08-27       Impact factor: 4.191

  1 in total
  6 in total

1.  The long-term course of subsolid nodules and predictors of interval growth on chest CT: a systematic review and meta-analysis.

Authors:  Linyu Wu; Chen Gao; Ning Kong; Xinjing Lou; Maosheng Xu
Journal:  Eur Radiol       Date:  2022-09-22       Impact factor: 7.034

2.  Diagnostic Efficacy of CT Radiomic Features in Pulmonary Invasive Mucinous Adenocarcinoma.

Authors:  Aizhu Sheng; Pengfei Zhou; Yizhai Ye; Keda Sun; Zhenhua Yang
Journal:  Scanning       Date:  2022-06-25       Impact factor: 1.750

3.  Multivariate Analysis on Development of Lung Adenocarcinoma Lesion from Solitary Pulmonary Nodule.

Authors:  Linxiang Yu; Bin Zhang; Haosheng Zou; Yi Shi; Liang Cheng; Ying Zhang; Haiwen Zhen
Journal:  Contrast Media Mol Imaging       Date:  2022-05-24       Impact factor: 3.009

4.  Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact.

Authors:  Yining Jiang; Siyu Che; Shuangchun Ma; Xinyan Liu; Yan Guo; Ailian Liu; Guosheng Li; Zhiyong Li
Journal:  Cancer Imaging       Date:  2021-01-06       Impact factor: 3.909

5.  Development and Validation of a Preoperative CT-Based Nomogram to Differentiate Invasive from Non-Invasive Pulmonary Adenocarcinoma in Solitary Pulmonary Nodules.

Authors:  Xin Song; Qingtao Zhao; Hua Zhang; Wenfei Xue; Zhifei Xin; Jianhua Xie; Xiaopeng Zhang
Journal:  Cancer Manag Res       Date:  2022-03-20       Impact factor: 3.989

6.  Invasive adenocarcinoma manifesting as pure ground glass nodule with different size: radiological characteristics differ while prognosis remains the same.

Authors:  Zijian Wang; Wei Zhu; Zhenzhen Lu; Wei Li; Jingyun Shi
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.